Jane Street’s ADMA Biologics ADMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$27.5M Buy
3,051,943
+2,592,519
+564% +$40.9M 0.03% 1510
2025
Q4
$8.38M Sell
459,424
-272,907
-37% -$4.6M 0.01% 2540
2025
Q3
$10.7M Buy
+732,331
New +$12.6M 0.01% 2327
2025
Q2
Hold
0
9507
2025
Q1
Sell
-59,989
Closed -$1.04M 9305
2024
Q4
$1.03M Sell
59,989
-375,137
-86% -$7.06M ﹤0.01% 5338
2024
Q3
$8.7M Buy
435,126
+535
+0.1% +$8.32K 0.01% 2075
2024
Q2
$4.86M Buy
434,591
+338,961
+354% +$2.84M 0.01% 2998
2024
Q1
$631K Sell
95,630
-58,924
-38% -$322K ﹤0.01% 6245
2023
Q4
$699K Buy
154,554
+69,118
+81% +$256K ﹤0.01% 6197
2023
Q3
$306K Sell
85,436
-326,182
-79% -$1.26M ﹤0.01% 7030
2023
Q2
$1.52M Buy
411,618
+396,943
+2,705% +$1.47M ﹤0.01% 4579
2023
Q1
$48.6K Sell
14,675
-161,185
-92% -$557K ﹤0.01% 8461
2022
Q4
$682K Buy
175,860
+128,022
+268% +$395K ﹤0.01% 5616
2022
Q3
$116K Buy
47,838
+33,205
+227% +$79.7K ﹤0.01% 8568
2022
Q2
$29K Sell
14,633
-609,733
-98% -$1.2M ﹤0.01% 9066
2022
Q1
$1.14M Buy
624,366
+548,579
+724% +$856K ﹤0.01% 5855
2021
Q4
$107K Buy
75,787
+42,281
+126% +$55.6K ﹤0.01% 9211
2021
Q3
$38K Sell
33,506
-21,971
-40% -$30.8K ﹤0.01% 9626
2021
Q2
$89K Buy
55,477
+32,865
+145% +$57.8K ﹤0.01% 9315
2021
Q1
$40K Buy
+22,612
New +$51.8K ﹤0.01% 8878
2020
Q4
Sell
-20,056
Closed -$48K 7409
2020
Q3
$48K Buy
+20,056
New +$55K ﹤0.01% 6921
2020
Q2
Sell
-35,333
Closed -$102K 7011
2020
Q1
$102K Sell
35,333
-128,158
-78% -$443K ﹤0.01% 4930
2019
Q4
$654K Buy
163,491
+29,196
+22% +$127K ﹤0.01% 3351
2019
Q3
$598K Buy
134,295
+75,921
+130% +$317K ﹤0.01% 3319
2019
Q2
$226K Buy
58,374
+11,711
+25% +$51.7K ﹤0.01% 4563
2019
Q1
$177K Buy
+46,663
New +$165K ﹤0.01% 4681

Other funds holding ADMA